aTyr Pharma, Inc.ATYRNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank92
3Y CAGR+16.2%
5Y CAGR+16.6%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+16.2%/yr
vs +58.1%/yr prior
5Y CAGR
+16.6%/yr
Consistent
Acceleration
-42.0pp
Decelerating
Percentile
P92
Near historical high
vs 5Y Ago
2.2x
Strong expansion
Streak
1 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.08 | -71.9% |
| 2024 | 3.84 | +275.3% |
| 2023 | 1.02 | +48.7% |
| 2022 | 0.69 | +127.8% |
| 2021 | 0.30 | -39.7% |
| 2020 | 0.50 | +82.7% |
| 2019 | 0.27 | +149.1% |
| 2018 | 0.11 | +121.7% |
| 2017 | 0.05 | +6.5% |
| 2016 | 0.05 | - |